A141080 Stock Overview
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
LigaChem Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩106,300.00 |
| 52 Week High | ₩143,600.00 |
| 52 Week Low | ₩43,200.00 |
| Beta | 0.97 |
| 11 Month Change | -14.21% |
| 3 Month Change | 16.43% |
| 1 Year Change | 128.85% |
| 33 Year Change | 121.69% |
| 5 Year Change | 311.22% |
| Change since IPO | 1,114.86% |
Recent News & Updates
Recent updates
LigaChem Biosciences (KOSDAQ:141080) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway
Sep 09
Here's Why LigaChem Biosciences (KOSDAQ:141080) Can Manage Its Debt Despite Losing Money
May 23A Look At The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)
Mar 29What Kind Of Shareholders Hold The Majority In LegoChem Biosciences, Inc.'s (KOSDAQ:141080) Shares?
Jan 28Estimating The Fair Value Of LegoChem Biosciences, Inc. (KOSDAQ:141080)
Dec 07
Shareholder Returns
| A141080 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -19.8% | -9.0% | -2.8% |
| 1Y | 128.8% | 33.1% | -3.4% |
Return vs Industry: A141080 exceeded the KR Life Sciences industry which returned 33.1% over the past year.
Return vs Market: A141080 exceeded the KR Market which returned -3.4% over the past year.
Price Volatility
| A141080 volatility | |
|---|---|
| A141080 Average Weekly Movement | 9.6% |
| Life Sciences Industry Average Movement | 8.8% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A141080's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A141080's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 157 | Yong Kim | www.legochembio.com |
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies.
LigaChem Biosciences Inc. Fundamentals Summary
| A141080 fundamental statistics | |
|---|---|
| Market cap | ₩3.87t |
| Earnings (TTM) | -₩33.95b |
| Revenue (TTM) | ₩76.22b |
50.8x
P/S Ratio-114.1x
P/E RatioIs A141080 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A141080 income statement (TTM) | |
|---|---|
| Revenue | ₩76.22b |
| Cost of Revenue | ₩16.02b |
| Gross Profit | ₩60.20b |
| Other Expenses | ₩94.14b |
| Earnings | -₩33.95b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -931.92 |
| Gross Margin | 78.98% |
| Net Profit Margin | -44.54% |
| Debt/Equity Ratio | 1.9% |
How did A141080 perform over the long term?
See historical performance and comparison